NCT06581432 2026-03-17
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Boehringer Ingelheim
Phase 2 Recruiting
Clinical Trials
4 trialsNCT07446855 2026-03-03
PARTHENON
AstraZeneca
Phase 1/2 Not yet recruiting
NCT07160725 2026-02-17
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting
NCT06725758 2026-01-15
TEADES
Orion Corporation, Orion Pharma
Phase 1/2 Recruiting